Literature DB >> 8784178

Phosphorylation of phospholamban by cAMP-dependent protein kinase enhances interactions between Ca-ATPase polypeptide chains in cardiac sarcoplasmic reticulum membranes.

S Negash1, L T Chen, D J Bigelow, T C Squier.   

Abstract

We have used spin-label EPR spectroscopy to examine possible alterations in protein-protein interactions that accompany the activation of the cardiac sarcoplasmic reticulum (SR) Ca-ATPase following the phosphorylation of phospholamban (PLB). Using a radioactive derivative of a maleimide spin label (MSL), we have developed conditions for the selective spin-labeling of the Ca-ATPase in both native cardiac and skeletal sarcoplasmic reticulum membranes. The rotational dynamics of the cardiac and skeletal Ca-ATPase isoforms in native SR membranes were measured using saturation transfer EPR. We report that the phosphorylation of PLB in cardiac SR results in a (1.8 +/- 0.2)-fold reduction in the overall rotational mobility of the Ca-ATPase. The alteration in the rotational dynamics of the Ca-ATPase is the direct result of the phosphorylation of PLB, and is not related to the phosphorylation of the Ca-ATPase or any other SR proteins since no alteration in the ST-EPR spectrum is observed as a result of conditions that phosphorylate the cardiac Ca-ATPase with ATP. Neither do the use of conditions that activate the Ca-ATPase in cardiac SR result in the alteration of the rotational dynamics or catalytic properties of the Ca-ATPase in skeletal SR where PLB is not expressed. Measurements of the rotational dynamics of stearic acid spin labels (SASL) incorporated into cardiac SR membranes with a nitroxide at the 5- and 12-positions using conventional EPR indicate that there is virtually no difference in the lipid acyl chain dynamics in cardiac SR membranes upon the phosphorylation of PLB. These results indicate that the decrease in the rotational dynamics of the Ca-ATPase in cardiac SR membranes associated with the phosphorylation of PLB is related to enhanced interactions between individual Ca-ATPase polypeptide chains due to (i) an alteration in the spatial arrangement of cardiac Ca-ATPase polypeptide chains within a defined oligomeric state or (ii) increased protein-protein associations. We suggest that altered interactions between Ca-ATPase polypeptide chains and PLB serves to modulate the activation barrier associated with calcium activation of the Ca-ATPase in cardiac SR membranes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8784178     DOI: 10.1021/bi960864q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  Kinetics studies of the cardiac Ca-ATPase expressed in Sf21 cells: new insights on Ca-ATPase regulation by phospholamban.

Authors:  J E Mahaney; J M Autry; L R Jones
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

2.  Alterations in sarcoplasmic reticulum function in female vastus lateralis with eccentric exercise.

Authors:  D Enns; H Green; R Tupling; M Burnett; S Grant; D Ranney
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

3.  Intermolecular interactions in the mechanism of skeletal muscle sarcoplasmic reticulum Ca(2+)-ATPase (SERCA1): evidence for a triprotomer.

Authors:  James E Mahaney; David D Thomas; Iain K Farrance; Jeffrey P Froehlich
Journal:  Biochemistry       Date:  2008-12-23       Impact factor: 3.162

4.  Phosphorylated phospholamban stabilizes a compact conformation of the cardiac calcium-ATPase.

Authors:  Sandeep Pallikkuth; Daniel J Blackwell; Zhihong Hu; Zhanjia Hou; Dane T Zieman; Bengt Svensson; David D Thomas; Seth L Robia
Journal:  Biophys J       Date:  2013-10-15       Impact factor: 4.033

5.  Phospholamban remains associated with the Ca2+- and Mg2+-dependent ATPase following phosphorylation by cAMP-dependent protein kinase.

Authors:  S Negash; Q Yao; H Sun; J Li; D J Bigelow; T C Squier
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

6.  Hydrophobic imbalance in the cytoplasmic domain of phospholamban is a determinant for lethal dilated cardiomyopathy.

Authors:  Delaine K Ceholski; Catharine A Trieber; Howard S Young
Journal:  J Biol Chem       Date:  2012-03-16       Impact factor: 5.157

7.  The Phospholamban Pentamer Alters Function of the Sarcoplasmic Reticulum Calcium Pump SERCA.

Authors:  John Paul Glaves; Joseph O Primeau; L Michel Espinoza-Fonseca; M Joanne Lemieux; Howard S Young
Journal:  Biophys J       Date:  2019-01-22       Impact factor: 4.033

8.  Cardiac Calcium ATPase Dimerization Measured by Cross-Linking and Fluorescence Energy Transfer.

Authors:  Daniel J Blackwell; Taylor J Zak; Seth L Robia
Journal:  Biophys J       Date:  2016-09-20       Impact factor: 4.033

9.  Interaction of a Sarcolipin Pentamer and Monomer with the Sarcoplasmic Reticulum Calcium Pump, SERCA.

Authors:  John Paul Glaves; Joseph O Primeau; Przemek A Gorski; L Michel Espinoza-Fonseca; M Joanne Lemieux; Howard S Young
Journal:  Biophys J       Date:  2019-11-28       Impact factor: 4.033

Review 10.  Nitroxyl (HNO) for treatment of acute heart failure.

Authors:  Alessia Arcaro; Giuseppe Lembo; Carlo G Tocchetti
Journal:  Curr Heart Fail Rep       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.